Cargando…
Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy
Ethylmalonic encephalopathy (EE) is an invariably fatal disease, characterized by the accumulation of hydrogen sulfide (H(2)S), a highly toxic compound. ETHE1, encoding sulfur dioxygenase (SDO), which takes part in the mitochondrial pathway that converts sulfide into harmless sulfate, is mutated in...
Autores principales: | Di Meo, Ivano, Auricchio, Alberto, Lamperti, Costanza, Burlina, Alberto, Viscomi, Carlo, Zeviani, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491831/ https://www.ncbi.nlm.nih.gov/pubmed/22903887 http://dx.doi.org/10.1002/emmm.201201433 |
Ejemplares similares
-
AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome
por: Di Meo, I, et al.
Publicado: (2017) -
Ethylmalonic encephalopathy and liver transplantation: long-term outcome of the first treated patient
por: Olivieri, Giorgia, et al.
Publicado: (2021) -
Ethylmalonic encephalopathy: Clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation
por: Ersoy, Melike, et al.
Publicado: (2020) -
Ethylmalonic encephalopathy masquerading as meningococcemia
por: Horton, Ari, et al.
Publicado: (2022) -
Neurological and Vascular Manifestations of Ethylmalonic Encephalopathy
por: TAVASOLI, Ali Reza, et al.
Publicado: (2017)